Quasi-VMAT in high-grade glioma radiation therapy

被引:2
|
作者
Fadda, G. [1 ]
Massazza, G. [1 ]
Zucca, S. [1 ]
Durzu, S. [1 ]
Meleddu, G. [1 ]
Possanzini, M. [1 ]
Farace, P. [1 ]
机构
[1] Reg Oncol Hosp, Dept Radiooncol, I-09121 Cagliari, Italy
关键词
Radiotherapy; Organs at risk; Hospital; Radiochemotherapy; Maximum dose; INTENSITY-MODULATED RADIOTHERAPY; CONFORMAL RADIOTHERAPY; PROSTATE-CANCER; PLAN QUALITY; ARC THERAPY; SHOOT IMRT; GLIOBLASTOMA; NUMBER; IMAT;
D O I
10.1007/s00066-012-0296-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To compare a quasi-volumetric modulated arc therapy (qVMAT) with three-dimensional conformal radiation therapy (3D-CRT) and intensity-modulated radiation therapy (IMRT) for the treatment of high-grade gliomas. The qVMAT technique is a fast method of radiation therapy in which multiple equispaced beams analogous to those in rotation therapy are radiated in succession. This study included 12 patients with a planning target volume (PTV) that overlapped at least one organ at risk (OAR). 3D-CRT was planned using 2-3 non-coplanar beams, whereby the field-in-field technique (FIF) was used to divide each field into 1-3 subfields to shield the OAR. The qVMAT strategy was planned with 15 equispaced beams and IMRT was planned using 9 beams with a total of 80 segments. Inverse planning for qVMAT and IMRT was performed by direct machine parameter optimization (DMPO) to deliver a homogenous dose distribution of 60 Gy within the PTV and simultaneously limit the dose received by the OARs to the recommended values. Finally, the effect of introducing a maximum dose objective (max. dose < 54 Gy) for a virtual OAR in the form of a 0.5 cm ring around the PTV was investigated. The qVMAT method gave rise to significantly improved PTV95% and conformity index (CI) values in comparison to 3D-CRT (PTV95% = 90.7 % vs. 82.0 %; CI = 0.79 vs. 0.74, respectively). A further improvement was achieved by IMRT (PTV95% = 94.4 %, CI = 0.78). In qVMAT and IMRT, the addition of a 0.5 cm ring around the PTV produced a significant increase in CI (0.87 and 0.88, respectively), but dosage homogeneity within the PTV was considerably reduced (PTV95% = 88.5 % and 92.3 %, respectively). The time required for qVMAT dose delivery was similar to that required using 3D-CRT. These findings suggest that qVMAT should be preferred to 3D-CRT for the treatment of high-grade gliomas. The qVMAT method could be applied in hospitals, for example, which have limited departmental resources and are not equipped with systems capable of VMAT delivery.
引用
收藏
页码:367 / 371
页数:5
相关论文
共 50 条
  • [1] Quasi-VMAT in high-grade glioma radiation therapyBestrahlung höhergradiger Gliome mit der Quasi-VMAT-Methode
    G. Fadda
    G. Massazza
    S. Zucca
    S. Durzu
    G. Meleddu
    M. Possanzini
    P. Farace
    Strahlentherapie und Onkologie, 2013, 189 (5) : 367 - 371
  • [2] Survival after radiation therapy for high-grade glioma
    Marra, Joana Spaggiari
    Mendes, Guilherme Paulao
    Yoshinari, Gerson Hiroshi, Jr.
    Guimaraes, Flavio da Silva
    Mazin, Suleimy Cristina
    de Oliveira, Harley Francisco
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2019, 24 (01) : 35 - 40
  • [3] Antiangiogenic therapy for high-grade glioma
    Khasraw, Mustafa
    Ameratunga, Malaka S.
    Grant, Robin
    Wheeler, Helen
    Pavlakis, Nick
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [4] Gene Therapy for High-Grade Glioma
    Iwami, Ken-ichiro
    Natsume, Atsushi
    Wakabayashi, Toshihiko
    NEUROLOGIA MEDICO-CHIRURGICA, 2010, 50 (09) : 727 - 736
  • [5] Hypofractionated Radiation Therapy With Concurrent Temozolamide for Recurrent High-Grade Glioma
    Garg, S.
    Palmer, J. D.
    Kim, H.
    Williams, N. L.
    Bhamidipati, D.
    Skowronski, J.
    Glass, J.
    Werner-Wasik, M.
    Kim, L.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E95 - E95
  • [6] Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge
    Navarria, Pierina
    Ascolese, Anna Maria
    Tomatis, Stefano
    Reggiori, Giacomo
    Clerici, Elena
    Villa, Elisa
    Maggi, Giulia
    Bello, Lorenzo
    Pessina, Federico
    Cozzi, Luca
    Scorsetti, Marta
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 37 - 44
  • [7] Metformin as Potential Therapy for High-Grade Glioma
    Mazurek, Marek
    Litak, Jakub
    Kamieniak, Piotr
    Kulesza, Bartlomiej
    Jonak, Katarzyna
    Baj, Jacek
    Grochowski, Cezary
    CANCERS, 2020, 12 (01)
  • [8] Ozone therapy for high-grade glioma: an overview
    Yanchu, Li
    Rong, Pu
    Rong, Cao
    Li, Zhang
    Xiaoyan, Yang
    Feng, Wang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Immunotherapy and radiation for high-grade glioma: a narrative review
    Fakhoury, Kareem R.
    Ney, Douglas E.
    Ormond, D. Ryan
    Rusthoven, Chad G.
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (05) : 2537 - 2570
  • [10] Stereotactic Radiation Treatment in Recurrent High-grade Glioma
    Abazeed, M.
    Niemierko, A.
    Abazeed, A.
    Loefller, J. S.
    Oh, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S277 - S277